speb/financial-data huggingface dataset:
MLAB balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 172496000.00
MLAB income_statement (quarterly, 2025-06-30) — Total Expenses: 56479000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 263247000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 337485000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 113753000.00
MLAB income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 3064000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 11735000.00
MLAB income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
MLAB income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
MLAB balance_sheet (quarterly, 2025-06-30) — Work In Process: 626000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Working Capital: -51236000.00
MLAB income_statement (quarterly, 2025-09-30) — +Operating Expense: 32607000.00
MLAB income_statement (quarterly, 2025-09-30) — +Total Revenue: 60737000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5090000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 40092000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -28777000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -1833000.00
MLAB cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 4534000.00
MLAB cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 4534000.00
MLAB income_statement (quarterly, 2025-09-30) — Basic Average Shares: 5512000.00
MLAB income_statement (quarterly, 2025-09-30) — Basic EPS: 0.45
MLAB cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 21279000.00
MLAB cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1092000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 15578000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Capital Stock: 365173000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 20422000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 20422000.00
MLAB cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -882000.00
MLAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -7883000.00
MLAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1092000.00
MLAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 8222000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1209000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -2577000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Inventory: -766000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -813000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Payable: -1209000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -3786000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1613000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1696000.00
MLAB cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -5448000.00
MLAB cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1696000.00
MLAB cash_flow (quarterly, 2025-09-30) — Changes In Cash: -753000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Common Stock: 365173000.00
MLAB cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -882000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 178468000.00
MLAB income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 23406000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2464000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Assets: 97433000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3815000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Debt: 4688000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 8503000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 14258000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 14258000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 48295000.00
MLAB cash_flow (quarterly, 2025-09-30) — Depreciation: 1315000.00
MLAB cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5849000.00
MLAB cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5849000.00
MLAB income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 5535000.00
MLAB income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.45
MLAB income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — EBIT: 4861000.00
MLAB income_statement (quarterly, 2025-09-30) — EBITDA: 10710000.00
MLAB cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -104000.00
MLAB cash_flow (quarterly, 2025-09-30) — End Cash Position: 20422000.00
MLAB cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -7883000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Finished Goods: 11432000.00
MLAB cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 7130000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3232000.00
MLAB income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 17763000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Goodwill: 188488000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 281756000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 41925000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Gross PPE: 60612000.00
MLAB income_statement (quarterly, 2025-09-30) — Gross Profit: 37331000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1432000.00
MLAB income_statement (quarterly, 2025-09-30) — Interest Expense: 2862000.00
MLAB income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2862000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Inventory: 27739000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Invested Capital: 353320000.00
MLAB cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1092000.00
MLAB cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 97000000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 11763000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 170164000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 181927000.00
MLAB cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 97000000.00
MLAB cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -103437000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Net Debt: 154430000.00
MLAB cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -95000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Income: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2476000.00
MLAB cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2476000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Interest Income: -2862000.00
MLAB cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -6437000.00
MLAB cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -6437000.00
MLAB income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2862000.00
MLAB cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -564000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Net PPE: 31835000.00
MLAB cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1092000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -103288000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1472000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 21661000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1472000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 21661000.00
MLAB income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 10710000.00
MLAB income_statement (quarterly, 2025-09-30) — Normalized Income: 2476000.00
MLAB cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 8222000.00
MLAB cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -95000.00
MLAB income_statement (quarterly, 2025-09-30) — Operating Income: 4724000.00
MLAB income_statement (quarterly, 2025-09-30) — Operating Revenue: 60737000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5510741.00
MLAB balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3592000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 4688000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -3232000.00
MLAB income_statement (quarterly, 2025-09-30) — Other Gand A: 17763000.00
MLAB income_statement (quarterly, 2025-09-30) — Other Income Expense: 137000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 93268000.00
MLAB cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1628000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 17855000.00
MLAB income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 137000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Other Payable: 8225000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Payables: 23070000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 25534000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 5588000.00
MLAB income_statement (quarterly, 2025-09-30) — Pretax Income: 1999000.00
MLAB cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1092000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Raw Materials: 15635000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Receivables: 40092000.00
MLAB income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 23406000.00
MLAB income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5849000.00
MLAB cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -103437000.00
MLAB income_statement (quarterly, 2025-09-30) — Research And Development: 5048000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -183473000.00
MLAB income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 9796000.00
MLAB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 27559000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Share Issued: 5510741.00
MLAB income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MLAB cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3812000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 178468000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -103288000.00
MLAB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (quarterly, 2025-09-30) — Tax Provision: -477000.00
MLAB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
MLAB balance_sheet (quarterly, 2025-09-30) — Total Assets: 430351000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 348632000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Debt: 190430000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 178468000.00
MLAB income_statement (quarterly, 2025-09-30) — Total Expenses: 56013000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 251883000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 332918000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 203588000.00
MLAB income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 4724000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 9755000.00
MLAB income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
MLAB income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MLAB balance_sheet (quarterly, 2025-09-30) — Work In Process: 672000.00
MLAB balance_sheet (quarterly, 2025-09-30) — Working Capital: 49138000.00
MLAB income_statement (quarterly, 2025-12-31) — +Operating Expense: 33820000.00
MLAB income_statement (quarterly, 2025-12-31) — +Total Revenue: 65126000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5253000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 40233000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -29901000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2523000.00
MLAB cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 4445000.00
MLAB cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 4445000.00
MLAB income_statement (quarterly, 2025-12-31) — Basic Average Shares: 5532000.00
MLAB income_statement (quarterly, 2025-12-31) — Basic EPS: 0.66
MLAB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 20422000.00
MLAB cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -732000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 14852000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 368555000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 28975000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 28975000.00
MLAB cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -884000.00
MLAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -9785000.00
MLAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -732000.00
MLAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 18754000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 124000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 5054000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Inventory: 596000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 244000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Payable: 124000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 5178000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -715000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Receivables: -819000.00
MLAB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4484000.00
MLAB cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -819000.00
MLAB cash_flow (quarterly, 2025-12-31) — Changes In Cash: 8237000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Common Stock: 368555000.00
MLAB cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -884000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 186691000.00
MLAB income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 23331000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2436000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Assets: 105632000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 3891000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Debt: 5156000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 9047000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 14558000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 14558000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 54395000.00
MLAB cash_flow (quarterly, 2025-12-31) — Depreciation: 1270000.00
MLAB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5715000.00
MLAB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5715000.00
MLAB income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 5565000.00
MLAB income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.65
MLAB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — EBIT: 7632000.00
MLAB income_statement (quarterly, 2025-12-31) — EBITDA: 13347000.00
MLAB cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 316000.00
MLAB cash_flow (quarterly, 2025-12-31) — End Cash Position: 28975000.00
MLAB cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -9785000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Finished Goods: 9281000.00
MLAB cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 18022000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1137000.00
MLAB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 18805000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Goodwill: 189303000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 278949000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 42756000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Gross PPE: 61500000.00
MLAB income_statement (quarterly, 2025-12-31) — Gross Profit: 41795000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 2072000.00
MLAB income_statement (quarterly, 2025-12-31) — Interest Expense: 3036000.00
MLAB income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3036000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Inventory: 26559000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Invested Capital: 352818000.00
MLAB cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -732000.00
MLAB cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
MLAB balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 10961000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 160971000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 171932000.00
MLAB cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
MLAB cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -8687000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Net Debt: 137152000.00
MLAB cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 281000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Income: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3630000.00
MLAB cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3630000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Interest Income: -3036000.00
MLAB cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -8687000.00
MLAB cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -8687000.00
MLAB income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3036000.00
MLAB cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -214000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Net PPE: 31599000.00
MLAB cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -732000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -92258000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1474000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 21831000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1474000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 21831000.00
MLAB income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 13347000.00
MLAB income_statement (quarterly, 2025-12-31) — Normalized Income: 3630000.00
MLAB cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 18754000.00
MLAB cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 281000.00
MLAB income_statement (quarterly, 2025-12-31) — Operating Income: 7975000.00
MLAB income_statement (quarterly, 2025-12-31) — Operating Revenue: 65126000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5524813.00
MLAB balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3934000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 5156000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1137000.00
MLAB income_statement (quarterly, 2025-12-31) — Other Gand A: 18805000.00
MLAB income_statement (quarterly, 2025-12-31) — Other Income Expense: -343000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 89646000.00
MLAB cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1262000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 17195000.00
MLAB income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -343000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Other Payable: 11576000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Payables: 28354000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 30790000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 5931000.00
MLAB income_statement (quarterly, 2025-12-31) — Pretax Income: 4596000.00
MLAB cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -732000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Raw Materials: 16555000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Receivables: 40233000.00
MLAB income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 23331000.00
MLAB income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5715000.00
MLAB cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -8687000.00
MLAB income_statement (quarterly, 2025-12-31) — Research And Development: 5029000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -180727000.00
MLAB income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 9986000.00
MLAB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 28791000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Share Issued: 5524813.00
MLAB income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
MLAB cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3382000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 186691000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -92258000.00
MLAB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (quarterly, 2025-12-31) — Tax Provision: 966000.00
MLAB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
MLAB balance_sheet (quarterly, 2025-12-31) — Total Assets: 434849000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 347662000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Debt: 180979000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 186691000.00
MLAB income_statement (quarterly, 2025-12-31) — Total Expenses: 57151000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 248158000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 329217000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 193763000.00
MLAB income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 7975000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 11525000.00
MLAB income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
MLAB income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MLAB balance_sheet (quarterly, 2025-12-31) — Work In Process: 723000.00
MLAB balance_sheet (quarterly, 2025-12-31) — Working Capital: 51237000.00
MLAB income_statement (annual, 2026-03-31) — +Operating Expense: 139759000.00
MLAB income_statement (quarterly, 2026-03-31) — +Operating Expense: 39457000.00
MLAB income_statement (annual, 2026-03-31) — +Total Revenue: 249130000.00
MLAB income_statement (quarterly, 2026-03-31) — +Total Revenue: 63724000.00
MLAB balance_sheet (annual, 2026-03-31) — Accounts Payable: 4928000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4928000.00
MLAB balance_sheet (annual, 2026-03-31) — Accounts Receivable: 44099000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 44099000.00
MLAB balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -30115000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -30115000.00
MLAB balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2569000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2569000.00
MLAB cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 18017000.00
MLAB cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 4485000.00
MLAB cash_flow (annual, 2026-03-31) — Amortization Of Intangibles: 18017000.00
MLAB cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 4485000.00
MLAB cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 0.00
MLAB income_statement (quarterly, 2026-03-31) — Basic Average Shares: 5544000.00
MLAB income_statement (quarterly, 2026-03-31) — Basic EPS: -0.75
MLAB cash_flow (annual, 2026-03-31) — Beginning Cash Position: 27321000.00
MLAB cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 28975000.00
MLAB balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 23368000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 23368000.00
MLAB cash_flow (annual, 2026-03-31) — Capital Expenditure: -3250000.00
MLAB cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -417000.00
MLAB balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 3687000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3687000.00
MLAB balance_sheet (annual, 2026-03-31) — Capital Stock: 375348000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Capital Stock: 375348000.00
MLAB balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 26928000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 26928000.00
MLAB balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 26928000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 26928000.00
MLAB cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -3523000.00
MLAB cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -884000.00
MLAB cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -41854000.00
MLAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -15759000.00
MLAB cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3250000.00
MLAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -417000.00
MLAB cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 42831000.00
MLAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 13962000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Account Payable: -1197000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -324000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Accrued Expense: 3497000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 6948000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Inventory: -4434000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Inventory: -974000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -255000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 259000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Payable: -1197000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Payable: -324000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 2300000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 6624000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: 608000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2146000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Receivables: -3206000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4127000.00
MLAB cash_flow (annual, 2026-03-31) — Change In Working Capital: -4987000.00
MLAB cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 3928000.00
MLAB cash_flow (annual, 2026-03-31) — Changes In Account Receivables: -3206000.00
MLAB cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -4127000.00
MLAB cash_flow (annual, 2026-03-31) — Changes In Cash: -2273000.00
MLAB cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2214000.00
MLAB balance_sheet (annual, 2026-03-31) — Common Stock: 375348000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Common Stock: 375348000.00
MLAB cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -3523000.00
MLAB cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -884000.00
MLAB balance_sheet (annual, 2026-03-31) — Common Stock Equity: 186245000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 186245000.00
MLAB balance_sheet (annual, 2026-03-31) — Construction In Progress: 1467000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1467000.00
MLAB income_statement (annual, 2026-03-31) — Cost Of Revenue: 90860000.00
MLAB income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 21519000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 2234000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2234000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Assets: 106268000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Assets: 106268000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 3687000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3687000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Debt: 5625000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Debt: 5625000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 9312000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 9312000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 14723000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 14723000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 14723000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 14723000.00
MLAB balance_sheet (annual, 2026-03-31) — Current Liabilities: 61898000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 61898000.00
MLAB cash_flow (annual, 2026-03-31) — Deferred Income Tax: -1292000.00
MLAB cash_flow (annual, 2026-03-31) — Deferred Tax: -1292000.00
MLAB cash_flow (annual, 2026-03-31) — Depreciation: 5254000.00
MLAB cash_flow (quarterly, 2026-03-31) — Depreciation: 1265000.00
MLAB cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 23271000.00
MLAB cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5750000.00
MLAB cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 23271000.00
MLAB cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5750000.00
MLAB income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 5544000.00
MLAB income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.75
MLAB income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4136000.00
MLAB income_statement (annual, 2026-03-31) — EBIT: 22706000.00
MLAB income_statement (quarterly, 2026-03-31) — EBIT: 1003000.00
MLAB income_statement (annual, 2026-03-31) — EBITDA: 45977000.00
MLAB income_statement (quarterly, 2026-03-31) — EBITDA: 6753000.00
MLAB cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 1880000.00
MLAB cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 167000.00
MLAB cash_flow (annual, 2026-03-31) — End Cash Position: 26928000.00
MLAB cash_flow (quarterly, 2026-03-31) — End Cash Position: 26928000.00
MLAB cash_flow (annual, 2026-03-31) — Financing Cash Flow: -41854000.00
MLAB cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -15759000.00
MLAB balance_sheet (annual, 2026-03-31) — Finished Goods: 10575000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Finished Goods: 10575000.00
MLAB cash_flow (annual, 2026-03-31) — Free Cash Flow: 39581000.00
MLAB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13545000.00
MLAB balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -3356000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -3356000.00
MLAB income_statement (annual, 2026-03-31) — General And Administrative Expense: 78658000.00
MLAB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 24132000.00
MLAB balance_sheet (annual, 2026-03-31) — Goodwill: 186863000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Goodwill: 186863000.00
MLAB balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 270210000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 270210000.00
MLAB balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 46668000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 46668000.00
MLAB balance_sheet (annual, 2026-03-31) — Gross PPE: 60728000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Gross PPE: 60728000.00
MLAB income_statement (annual, 2026-03-31) — Gross Profit: 158270000.00
MLAB income_statement (quarterly, 2026-03-31) — Gross Profit: 42205000.00
MLAB income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 0.00
MLAB cash_flow (annual, 2026-03-31) — Income Tax Paid Supplemental Data: 1870000.00
MLAB balance_sheet (annual, 2026-03-31) — Income Tax Payable: 4745000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 4745000.00
MLAB income_statement (annual, 2026-03-31) — Interest Expense: 10692000.00
MLAB income_statement (quarterly, 2026-03-31) — Interest Expense: 2596000.00
MLAB income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 10692000.00
MLAB income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2596000.00
MLAB cash_flow (annual, 2026-03-31) — Interest Paid Supplemental Data: 10017000.00
MLAB balance_sheet (annual, 2026-03-31) — Inventory: 26373000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Inventory: 26373000.00
MLAB balance_sheet (annual, 2026-03-31) — Invested Capital: 337727000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Invested Capital: 337727000.00
MLAB cash_flow (annual, 2026-03-31) — Investing Cash Flow: -3250000.00
MLAB cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -417000.00
MLAB cash_flow (annual, 2026-03-31) — Issuance Of Debt: 107500000.00
MLAB cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
MLAB balance_sheet (annual, 2026-03-31) — Land And Improvements: 889000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 889000.00
MLAB balance_sheet (annual, 2026-03-31) — Long Term Debt: 145857000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 145857000.00
MLAB balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 145857000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 145857000.00
MLAB cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 107500000.00
MLAB cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
MLAB cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -134249000.00
MLAB cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -14687000.00
MLAB balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 3658000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3658000.00
MLAB cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
MLAB balance_sheet (annual, 2026-03-31) — Net Debt: 124554000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Net Debt: 124554000.00
MLAB income_statement (annual, 2026-03-31) — Net Income: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Income: -4136000.00
MLAB income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4136000.00
MLAB income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4136000.00
MLAB income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4136000.00
MLAB income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4136000.00
MLAB cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 6712000.00
MLAB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4136000.00
MLAB income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4136000.00
MLAB cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
MLAB income_statement (annual, 2026-03-31) — Net Interest Income: -10692000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Interest Income: -2596000.00
MLAB cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -26749000.00
MLAB cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -14687000.00
MLAB cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -26749000.00
MLAB cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -14687000.00
MLAB income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -10692000.00
MLAB income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2596000.00
MLAB cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -11582000.00
MLAB cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -188000.00
MLAB balance_sheet (annual, 2026-03-31) — Net PPE: 30613000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Net PPE: 30613000.00
MLAB cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3250000.00
MLAB cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -417000.00
MLAB balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -83965000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -83965000.00
MLAB balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 1501000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1501000.00
MLAB balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 20085000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 20085000.00
MLAB balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1501000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1501000.00
MLAB balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 20085000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 20085000.00
MLAB income_statement (annual, 2026-03-31) — Normalized EBITDA: 45977000.00
MLAB income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6753000.00
MLAB income_statement (annual, 2026-03-31) — Normalized Income: 6712000.00
MLAB income_statement (quarterly, 2026-03-31) — Normalized Income: -4136000.00
MLAB cash_flow (annual, 2026-03-31) — Operating Cash Flow: 42831000.00
MLAB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 13962000.00
MLAB income_statement (annual, 2026-03-31) — Operating Income: 18511000.00
MLAB income_statement (quarterly, 2026-03-31) — Operating Income: 2748000.00
MLAB income_statement (annual, 2026-03-31) — Operating Revenue: 249130000.00
MLAB income_statement (quarterly, 2026-03-31) — Operating Revenue: 63724000.00
MLAB balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 5524931.00
MLAB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 5524931.00
MLAB balance_sheet (annual, 2026-03-31) — Other Current Assets: 3620000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3620000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 5625000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5625000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: -3356000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -3356000.00
MLAB income_statement (annual, 2026-03-31) — Other Gand A: 78658000.00
MLAB income_statement (quarterly, 2026-03-31) — Other Gand A: 24132000.00
MLAB income_statement (annual, 2026-03-31) — Other Income Expense: 4195000.00
MLAB income_statement (quarterly, 2026-03-31) — Other Income Expense: -1745000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 83347000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 83347000.00
MLAB cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1259000.00
MLAB cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -2881000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 19155000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 19155000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 13662000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 13662000.00
MLAB income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 4195000.00
MLAB income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1745000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Payable: 16689000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Payable: 16689000.00
MLAB balance_sheet (annual, 2026-03-31) — Other Properties: 31346000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Other Properties: 31346000.00
MLAB balance_sheet (annual, 2026-03-31) — Payables: 35629000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Payables: 35629000.00
MLAB balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 37863000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 37863000.00
MLAB balance_sheet (annual, 2026-03-31) — Prepaid Assets: 5248000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 5248000.00
MLAB income_statement (annual, 2026-03-31) — Pretax Income: 12014000.00
MLAB income_statement (quarterly, 2026-03-31) — Pretax Income: -1593000.00
MLAB cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
MLAB balance_sheet (annual, 2026-03-31) — Properties: 0.00
MLAB balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
MLAB cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
MLAB cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: 0.00
MLAB cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3250000.00
MLAB cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -417000.00
MLAB balance_sheet (annual, 2026-03-31) — Raw Materials: 14873000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Raw Materials: 14873000.00
MLAB balance_sheet (annual, 2026-03-31) — Receivables: 44099000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Receivables: 44099000.00
MLAB income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 90860000.00
MLAB income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 21519000.00
MLAB income_statement (annual, 2026-03-31) — Reconciled Depreciation: 23271000.00
MLAB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5750000.00
MLAB cash_flow (annual, 2026-03-31) — Repayment Of Debt: -134249000.00
MLAB cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -14687000.00
MLAB income_statement (annual, 2026-03-31) — Research And Development: 20308000.00
MLAB income_statement (quarterly, 2026-03-31) — Research And Development: 5247000.00
MLAB balance_sheet (annual, 2026-03-31) — Retained Earnings: -185747000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -185747000.00
MLAB income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 40793000.00
MLAB income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 10078000.00
MLAB income_statement (annual, 2026-03-31) — Selling General And Administration: 119451000.00
MLAB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 34210000.00
MLAB balance_sheet (annual, 2026-03-31) — Share Issued: 5524931.00
MLAB balance_sheet (quarterly, 2026-03-31) — Share Issued: 5524931.00
MLAB income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
MLAB income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MLAB cash_flow (annual, 2026-03-31) — Stock Based Compensation: 17868000.00
MLAB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6793000.00
MLAB balance_sheet (annual, 2026-03-31) — Stockholders Equity: 186245000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 186245000.00
MLAB balance_sheet (annual, 2026-03-31) — Tangible Book Value: -83965000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -83965000.00
MLAB income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (annual, 2026-03-31) — Tax Provision: 5302000.00
MLAB income_statement (quarterly, 2026-03-31) — Tax Provision: 2543000.00
MLAB income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
MLAB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
MLAB balance_sheet (annual, 2026-03-31) — Total Assets: 427747000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Total Assets: 427747000.00
MLAB balance_sheet (annual, 2026-03-31) — Total Capitalization: 332102000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 332102000.00
MLAB balance_sheet (annual, 2026-03-31) — Total Debt: 155169000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Total Debt: 155169000.00
MLAB balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 186245000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 186245000.00
MLAB income_statement (annual, 2026-03-31) — Total Expenses: 230619000.00
MLAB income_statement (quarterly, 2026-03-31) — Total Expenses: 60976000.00
MLAB balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 241502000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 241502000.00
MLAB balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 321479000.00
MLAB balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 321479000.00